Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1971 1
1973 2
1982 1
1988 1
1991 1
1992 2
2001 2
2002 1
2003 1
2005 3
2006 1
2007 4
2008 7
2009 3
2010 8
2011 6
2012 5
2013 11
2014 8
2015 8
2016 10
2017 9
2018 16
2019 12
2020 19
2021 19
2022 20
2023 17
2024 20
2025 21

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

201 results

Results by year

Filters applied: . Clear all
Page 1
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Nair P, Terrier B, Walz B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Börjesson Sjö L, Fan Y, Jison M, McCrae C, Necander S, Shavit A, Walton C, Merkel PA; MANDARA Study Group. Wechsler ME, et al. Among authors: mccrae c. N Engl J Med. 2024 Mar 7;390(10):911-921. doi: 10.1056/NEJMoa2311155. Epub 2024 Feb 23. N Engl J Med. 2024. PMID: 38393328 Clinical Trial.
Eosinophil Depletion with Benralizumab for Eosinophilic Esophagitis.
Rothenberg ME, Dellon ES, Collins MH, Bredenoord AJ, Hirano I, Peterson KA, Brooks L, Caldwell JM, Fjällbrant H, Grindebacke H, Ho CN, Keith M, McCrae C, Sinibaldi D, White WI, Datto CJ; MESSINA Trial Investigators. Rothenberg ME, et al. Among authors: mccrae c. N Engl J Med. 2024 Jun 27;390(24):2252-2263. doi: 10.1056/NEJMoa2313318. N Engl J Med. 2024. PMID: 38924732 Clinical Trial.
Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial.
Gauvreau GM, Sehmi R, FitzGerald JM, Leigh R, Cockcroft DW, Davis BE, Mayers I, Boulet LP, Al-Sajee D, Salter BM, Cusack RP, Ho T, Whetstone CE, Alsaji N, Satia I, Killian KJ, Mitchell PD, Magee IP, Bergeron C, Bhutani M, Werkström V, Durżyński T, Shoemaker K, Katial RK, Jison M, Newbold P, McCrae C, O'Byrne PM. Gauvreau GM, et al. Among authors: mccrae c. Eur Respir J. 2024 Sep 12;64(3):2400512. doi: 10.1183/13993003.00512-2024. Print 2024 Sep. Eur Respir J. 2024. PMID: 39060015 Free PMC article. Clinical Trial.
Two-year efficacy and safety of anti-interleukin-5/receptor therapy for eosinophilic granulomatosis with polyangiitis.
Merkel PA, Nair PK, Khalidi N, Terrier B, Hellmich B, Bourdin A, Jayne DRW, Jackson DJ, Roufosse F, Pagnoux C, Specks U, Börjesson Sjö L, Ho CN, Jison M, McCrae C, Necander S, Rodríguez-Suárez E, Shavit A, Walton C, Wechsler ME; MANDARA Study Group. Merkel PA, et al. Among authors: mccrae c. Ann Rheum Dis. 2025 Nov;84(11):1888-1899. doi: 10.1016/j.ard.2025.06.2131. Epub 2025 Aug 7. Ann Rheum Dis. 2025. PMID: 40781045 Free article. Clinical Trial.
Nonrestorative sleep.
Stone KC, Taylor DJ, McCrae CS, Kalsekar A, Lichstein KL. Stone KC, et al. Among authors: mccrae cs. Sleep Med Rev. 2008 Aug;12(4):275-88. doi: 10.1016/j.smrv.2007.12.002. Epub 2008 Jun 6. Sleep Med Rev. 2008. PMID: 18539057 Review.
IgG autoantibodies in bullous pemphigoid induce a pathogenic MyD88-dependent pro-inflammatory response in keratinocytes.
Bao L, Guerrero-Juarez CF, Li J, Pigors M, Emtenani S, Liu Y, Mansini AP, Wang YF, Ahmed A, Ishii N, Hashimoto T, Perez White BE, Green S, Kunstman K, Nowak NC, Cole C, Sarkar MK, Gudjonsson JE, Virgilia M, Sverdlov M, McAlexander MA, McCrae C, Nazaroff CD, Schmidt E, Amber KT. Bao L, et al. Among authors: mccrae c. Nat Commun. 2025 Aug 6;16(1):7254. doi: 10.1038/s41467-025-62495-2. Nat Commun. 2025. PMID: 40769980 Free PMC article.
IgG autoantibodies in bullous pemphigoid directly induce a pathogenic MyD88-dependent pro-inflammatory response in keratinocytes.
Bao L, Juarez CFG, Li J, Pigors M, Emtenani S, Liu Y, Ahmed A, Ishii N, Hashimoto T, White BEP, Green S, Kunstman K, Nowak NC, Cole C, Macias V, Sverdlov M, McAlexander MA, McCrae C, Nazaroff CD, Schmidt E, Amber KT. Bao L, et al. Among authors: mccrae c. bioRxiv [Preprint]. 2024 Oct 11:2024.10.07.616103. doi: 10.1101/2024.10.07.616103. bioRxiv. 2024. Update in: Nat Commun. 2025 Aug 6;16(1):7254. doi: 10.1038/s41467-025-62495-2. PMID: 39569141 Free PMC article. Updated. Preprint.
IL-33 is associated with alveolar dysfunction in patients with viral lower respiratory tract disease.
Scott IC, Zuydam NV, Cann JA, Negri VA, Tsafou K, Killick H, Liu Z, McCrae C, Rees DG, England E, Guscott MA, Houslay K, McCormick D, Freeman A, Schofield D, Freeman A, Cohen ES, Thwaites R, Brohawn Z, Platt A, Openshaw PJM, Semple MG, Baillie JK, Wilkinson T; ISARIC4C Investigators. Scott IC, et al. Among authors: mccrae c. Mucosal Immunol. 2025 Apr;18(2):312-325. doi: 10.1016/j.mucimm.2024.12.001. Epub 2024 Dec 9. Mucosal Immunol. 2025. PMID: 39662674 Free PMC article.
Pharmacokinetics/pharmacodynamics of benralizumab in chronic rhinosinusitis with nasal polyps: Phase III, randomized, placebo-controlled OSTRO trial.
Emson C, Han JK, Hopkins C, Asimus S, Cann JA, Chain D, Wu Y, Reddy Y, McCrae C, Cohen D, Kreindler JL, Werkström V, Jison M, Wagenmann M, Bachert C. Emson C, et al. Among authors: mccrae c. Br J Clin Pharmacol. 2024 Aug;90(8):1952-1963. doi: 10.1111/bcp.16087. Epub 2024 May 7. Br J Clin Pharmacol. 2024. PMID: 38715387 Free article. Clinical Trial.
201 results